STAT

JUNE 25, 2023

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention. Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him.

Vaccines 98

Vaccines 98

Drug Topics

JUNE 25, 2023

Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare.

98

98

The People's Pharmacy

JUNE 25, 2023

Modern medicine is skeptical of most home remedies. It relegates them to the category of anecdotal old wives’ tales. Instead, prescribers prefer FDA-approved medicines that are supported by clinical trials. We too like randomized, double-blind, placebo-controlled studies. But sometimes evidence comes in the form of experience, and sometimes experiments vindicate the old wives.

Medical Schools 77

Medical Schools FDA 77

pharmaphorum

JUNE 25, 2023

NHS a laggard on patient outcomes, says think tank Phil.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Med Ed 101

JUNE 25, 2023

I enjoy giving back to the people who follow my blog and podcast! We are thrilled to introduce our new Pharmacology Crossword Puzzle Activity Book, designed to challenge and enhance your knowledge of this fascinating subject. For a VERY LIMITED TIME, I’m pricing the book AS LOW AS AMAZON WILL LET ME. My only request […] The post New Book!

52

52

The People's Pharmacy

JUNE 25, 2023

Have you experienced peculiar symptoms from taking certain medications or even eating certain foods? Eating beets, for example, may turn urine and stools red. Drinking a lot of carrot juice can color the skin orange. What might account for black stools? Readers have asked about dietary supplements as well as medications. Do Supplements or Medications Cause Black Stools?

Compounding 55

Compounding 55

PharmaShots

JUNE 25, 2023

Shots: The approval was based on the P-IIb/III trial (ALLEGRO) evaluating Litfulo vs PBO in 718 patients aged 12yrs. with ≥50% scalp hair loss as measured SALT at 118 sites in 18 countries. Patients initially assigned to PBO switched to Litfulo (50 or 200mg loading dose + 50mg) for an additional 24wks. The results showed that 23% vs 1.6% treated with Litfulo (50mg) had ≥80% scalp hair coverage (SALT≤20) after 6mos.

FDA 40

FDA 40

PharmExec

JUNE 25, 2023

Delivering on the mission of personalized patient support

52

52

STAT

JUNE 25, 2023

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage. There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

140

140

The People's Pharmacy

JUNE 25, 2023

For years, some doctors have insisted that taking vitamins is a waste of effort, not to mention money. They believe that simply eating a well-balanced diet should provide all the nutrients any of us needs. (Never mind that many people find it difficult to follow a balanced diet, for a variety of reasons.) Other healthcare practitioners are sure that vitamin supplements are helpful.

60

60

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA